FDA Drug Application (021507) for PREVACID NAPRAPAC 250 (COPACKAGED) by TAKEDA PHARMS NA

Back to FDA Applications sponsored by TAKEDA PHARMS NA

Application Number021507
Product Number002
FormCAPSULE, DELAYED REL PELLETS, TABLET;ORAL
Dosage15MG,N/A;N/A,250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePREVACID NAPRAPAC 250 (COPACKAGED)
Active IngredientLANSOPRAZOLE; NAPROXEN

Active IngredientCount
List of drugs with Active Ingredient LANSOPRAZOLE9
List of drugs with Active Ingredient NAPROXEN8


Back to FDA Applications sponsored by TAKEDA PHARMS NA